medicina59巻7号

2022年06月発行

特集 抗菌薬の使い方—敵はコロナだけにあらず！ 今こそ基本に立ち返る 感染症サイドから考える抗菌薬の使い方—症例をもとに

カテーテル関連血流感染症（CRBSI）—COVID-19流行下における対策

著者： 柏木克仁¹ 吉澤定子²³

所属機関： ¹東邦大学医療センター大森病院総合診療・急病センター（感染症） ²東邦大学医学部臨床検査医学講座 ³東邦大学医学部微生物・感染症学講座

ページ範囲：P.1148 - P.1154

Point
◎カテーテル関連血流感染症（CRBSI），中心ライン関連血流感染症（CLABSI）の定義を再度確認する．
◎施設ごとの検査方法や評価方法を考慮する．
◎カテーテルの種類や菌種，合併症（血栓性静脈炎など）により治療期間は変化する．
◎質量分析機器の活用により有効抗菌薬投与期間までの日数が改善する可能性がある．
◎新型コロナウイルス感染症（COVID-19）流行時においても基本的な感染対策の徹底が発生率を低下させる．

参考文献

1）Mermel LA, et al：Guidelines for the management of intravascular catheter-related infections.Clin Infect Dis 32：1249-1272, 2001

2）Mermel LA, et al：IDSA Guidelines for intravascular catheter-related infection clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection；2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49：1-45, 2009

3）Crnich CJ, Maki DG：The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term Devices. Clin Infect Dis 34：1232-1242, 2002

4）CDC：Bloodstream Infection Event（Central Line-Associated Bloodstream Infection and Non-central Line Associated Bloodstream Infection）. 2022

5）日本環境感染学会：医療器具関連感染サーベイランス2009年4月〜2020年12月データサマリ．

6）O'Grady NP, et al：Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 52：e162-93, 2011

7）Crnich CJ, Maki DG：The promise of novel technology for the prevention of intravascular device-related bloodstream infection. Ⅱ. long-term devices. Clin Infect Dis 34：1362-1368, 2002

8）Safdar N, Maki DG：Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term,noncuffed central venous catheters. Criti Care Med 30：2632-2635, 2002

9）Raad I, et al：Ultrastructural analysis of indwelling vascular catheters；A quantitative relationship between luminal colonization and duration of placement. J Infect Dis 168：400-407, 1993

10）Weiner LM, et al：Antimicrobial-resistant pathogens associated with healthcare-associated infections；Summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014. Infect Control Hosp Epidemiol 37：1288-1301, 2016

11）JAID/JSC感染症治療ガイド・ガイドライン作成委員会：JAID/JSC感染症治療ガイドライン2017—敗血症およびカテーテル関連血流感染症．日化療会誌66：82-117, 2018

12）Huang AM, et al：Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis 57：1237-1245, 2013

13）Raad I, et al：Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia；Remove or retain? Clin Infect Dis 49：1187-1194, 2009

14）Raad I, et al：Successful salvage of central venous catheters in patients with catheter-related or central line-associated bloodstream infections by using a catheter lock solution consisting of minocycline, EDTA, and 25％ ethanol. Antimicrob Agents Chemother 60：3426-3432, 2016

15）Rickard CM, et al：Routine versus clinically indicated replacement of peripheral intravenous catheters；A randomised controlled equivalence trial. Lancet 380：1066-1074, 2012

16）Webster J,et al：Clinically-indicated replacement versus routine replacement of peripheral venous catheters（Review）. Cochrane Database Syst Rev 1：CD007798, 2019

17）Coleman JJ, et al：COVID-19；To be or not to be；That is the diagnostic question. Postgrad Med J 96：392-398, 2020

18）Ippolito M, et al：Bloodstream infections in hospitalized patients with COVID-19；A systematic review and meta-analysis. Microorganisms 9：2016, 2021

19）Buetti N, et al：COVID-19 increased the risk of ICU-acquired bloodstream infections；A case-cohort study from the multicentric OUTCOMEREA network. Intensive Care Med 47：180-187, 2021

20）Heidempergher M, et al：Targeting COVID-19 prevention in hemodialysis facilities is associated with a drastic reduction in central venous catheter-related infections. J Nephrol 34：345-353, 2021